简体中文 | 繁體中文 | English

Press Releases

2023-06-28 08:15 Express Your Creativity with Lush-Florist's New Line of Floral Design Services and DIY Boxes
2023-06-27 16:03 Tezos Activates ‘Nairobi’ Upgrade With 8X Increase In Transactions Per Second
2023-06-27 15:24 SLB Announces Second-Quarter 2023 Results Conference Call
2023-06-27 09:47 i2c Inc. Appoints Jacqueline White as President to Drive Growth and Accelerate Its Core Banking Business
2023-06-27 09:39 Translated Unleashes Full GPT-4 Potential for Businesses Operating in Languages Other Than English
2023-06-27 09:36 Calastone Collaborates With Schroders to Make Tokenisation a Reality
2023-06-27 09:34 Galderma Raises Approximately USD 1 Billion for Newly Issued Shares in a Private Placement Round
2023-06-27 09:30 GTJAI Announced that It Achieved "Carbon Neutrality" at Operational Level for the First Time
2023-06-27 09:14 Vertex Ventures HC Announces $200 Million Fund III to Drive Innovation in Healthcare
2023-06-27 09:05 Topsoe Accelerates Global Green Hydrogen Economy with AVEVA Software
2023-06-27 08:48 Sumitomo Mitsui DS Asset Management Selects Burgiss’ Full Suite of Private Capital Data and Analytics to Support Its Asset Management Business
2023-06-26 22:39 Dubai's Creative Economy Soars: #1 Global Ranking in FDI Projects
2023-06-26 19:12 “Hong Kong International Dragon Boat Races” Returned to Victoria Harbour
2023-06-26 15:14 Metatime Has Successfully Secured a Total Investment of $25 Million to Date for Its Blockchain Ecosystem
2023-06-26 09:57 Jardiance® recommended for the treatment of adults with chronic kidney disease in the EU
2023-06-26 09:49 Pivotal Phase 3 Data Presented at ISTH 2023 Congress Spotlight TAK-755 Prophylaxis for Patients with Congenital Thrombotic Thrombocytopenic Purpura (cTTP)
2023-06-26 09:43 MSCI 2023 Market Classification Review
2023-06-26 09:37 ODDITY Announces Filing of Registration Statement for Proposed Initial Public Offering
2023-06-26 09:35 Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer Ingelheim and Zealand Pharma Phase II trial with survodutide (BI 456906)1
2023-06-26 09:30 Allianz SE Supervisory Board Extends Mandates for Barbara Karuth-Zelle and Christopher Townsend through 2028